The obstructive sleep apnea market dynamics are anticipated to change in the coming years owing to the expected approval of emerging therapies focused on treating obstructive sleep apnea during
The expected launch of therapies by several pharma companies such as ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others
The opioid use disorder market is expected to grow in the coming years due to factors like an increase in the patient pool and the expected entry of emerging therapies by leading companies such
Next-generation immunotherapies market is expected to grow significantly during the forecast period (2023-2032) owing to the increasing number of cancer cases in the 7MM, accompanied by the
Parkinson's disease is a progressive disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which controls movement. These nerve cells